NCT02690727View on ClinicalTrials.gov

To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Healthy
Interventions
DRUG

RP6530

Single oral dose

Trial Locations (1)

H3P 3P1

Algorithme Pharma Inc, Québec

All Listed Sponsors
lead

Rhizen Pharmaceuticals SA

INDUSTRY

NCT02690727 - To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers | Biotech Hunter | Biotech Hunter